Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Sander

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
NPJ Vaccines|November 15, 2022
Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomersJannick Prentoe, Christoph M Janitzek, Rodrigo Velázquez-Moctezuma, et al.
Vaccines|February 10, 2021
The Immunogenicity of Capsid-Like Particle Vaccines in Combination with Different Adjuvants Using Different Routes of AdministrationChristoph M Janitzek, Philip H R Carlsen, Susan Thrane, et al.
Vaccines|July 27, 2024
Protection of K18-hACE2 Mice against SARS-CoV-2 Challenge by a Capsid Virus-like Particle-Based VaccineSebenzile K Myeni, Anouk A Leijs, Peter J Bredenbeek, et al.
Plos One|July 30, 2021
Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigensJannick Prentoe, Christoph M Janitzek, Rodrigo Velázquez-Moctezuma, et al.
Nucleic Acids Research|November 21, 2013
DNA secondary structures are associated with recombination in major Plasmodium falciparum variable surface antigen gene familiesAdam F Sander, Thomas Lavstsen, Thomas S Rask, et al.
Journal of Virology|June 29, 2022
An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 MiceLinda van Oosten, Kexin Yan, Daniel J Rawle, et al.
Frontiers in Immunology|April 28, 2022
A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus MacaquesAriane Volkmann, Gerrit Koopman, Petra Mooij, et al.
Vaccines|July 19, 2020
A Vaccine Displaying a Trimeric Influenza-A HA Stem Protein on Capsid-Like Particles Elicits Potent and Long-Lasting Protection in MiceSusan Thrane, Kara-Lee Aves, Ida E M Uddbäck, et al.
Frontiers in Immunology|June 25, 2019
<i>Pf</i>s230 and <i>Pf</i>s48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against <i>Plasmodium falciparum</i>Susheel K Singh, Susan Thrane, Bishwanath K Chourasia, et al.
Journal of Nanobiotechnology|April 28, 2016
Bacterial superglue enables easy development of efficient virus-like particle based vaccinesSusan Thrane, Christoph M Janitzek, Sungwa Matondo, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
NPJ Vaccines|November 15, 2022
Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomersJannick Prentoe, Christoph M Janitzek, Rodrigo Velázquez-Moctezuma, et al.
Vaccines|February 10, 2021
The Immunogenicity of Capsid-Like Particle Vaccines in Combination with Different Adjuvants Using Different Routes of AdministrationChristoph M Janitzek, Philip H R Carlsen, Susan Thrane, et al.
Vaccines|July 27, 2024
Protection of K18-hACE2 Mice against SARS-CoV-2 Challenge by a Capsid Virus-like Particle-Based VaccineSebenzile K Myeni, Anouk A Leijs, Peter J Bredenbeek, et al.
Plos One|July 30, 2021
Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigensJannick Prentoe, Christoph M Janitzek, Rodrigo Velázquez-Moctezuma, et al.
Nucleic Acids Research|November 21, 2013
DNA secondary structures are associated with recombination in major Plasmodium falciparum variable surface antigen gene familiesAdam F Sander, Thomas Lavstsen, Thomas S Rask, et al.
Journal of Virology|June 29, 2022
An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 MiceLinda van Oosten, Kexin Yan, Daniel J Rawle, et al.
Frontiers in Immunology|April 28, 2022
A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus MacaquesAriane Volkmann, Gerrit Koopman, Petra Mooij, et al.
Vaccines|July 19, 2020
A Vaccine Displaying a Trimeric Influenza-A HA Stem Protein on Capsid-Like Particles Elicits Potent and Long-Lasting Protection in MiceSusan Thrane, Kara-Lee Aves, Ida E M Uddbäck, et al.
Frontiers in Immunology|June 25, 2019
<i>Pf</i>s230 and <i>Pf</i>s48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against <i>Plasmodium falciparum</i>Susheel K Singh, Susan Thrane, Bishwanath K Chourasia, et al.
Journal of Nanobiotechnology|April 28, 2016
Bacterial superglue enables easy development of efficient virus-like particle based vaccinesSusan Thrane, Christoph M Janitzek, Sungwa Matondo, et al.
Pageof 6